Strategic Partnerships Ibex is expanding through global clinical deployments and partnerships with laboratories and healthcare providers, presenting ongoing upsell opportunities for expanded AI diagnostics integrations and co-developed solutions.

Clinical Adoption The platform is already deployed in routine pathology labs and is positioned to scale with additional tumor types, workflows, and high-volume settings, opening conversations with hospitals seeking AI-enabled quality control and throughput gains.

Advisory Expansion New Biopharma Advisory Board appointments suggest opportunities to partner with pharmaceutical companies on companion diagnostics, real-world evidence studies, and co-development of AI-assisted patient stratification.

Integrated Workflows Recent integrations with Health Network Laboratories and mTuitive indicate a demand for end-to-end, standardized reporting and seamless AI-assisted pathology workflows across LIS/EMR ecosystems.

Financial Scale With substantial revenue and significant funding, Ibex can be pursued for multi-site contract wins, enterprise licensing, and long-term service agreements targeting large health systems seeking scalable AI pathology solutions.